Trius Adds Seasoned Newfoundland Exploration Advisor
FREDERICTON, New Brunswick, Sept. 16, 2020 (GLOBE NEWSWIRE) — Trius Investments Inc. (TSXV: TRU) (“Trius” or the “Company”) is pleased […]
Class 1 Nickel Commences Geophysics Programs
Geotech Ltd has been appointed to fly Heliborne VTEM™ and Horizontal Magnetic Gradiometer geophysical surveys over the entire 20 square […]
HOOKIPA Pharma’s LCMV-based Immunotherapy for HPV16+ Cancers Demonstrates High Immunogenicity, According to Peer Reviewed Article
Peer reviewed article in OncoImmunology demonstrates promising preclinical results for the novel cancer therapy targeting Human Papillomavirus 16 (HPV16) E6/E7 HPV […]
L Brands Announces Proposed $750 Million Offering of Senior Notes Due 2030
COLUMBUS, Ohio, Sept. 16, 2020 (GLOBE NEWSWIRE) — L Brands, Inc. (NYSE: LB) announced today that it is offering to […]
L Brands Launches Tender Offers for 5.625% Senior Notes due 2022, 5.625% Senior Notes due 2023, 7.60% Notes due 2037 and 6.95% Exchange Debentures due 2033
COLUMBUS, Ohio, Sept. 16, 2020 (GLOBE NEWSWIRE) — L Brands, Inc. (NYSE: LB) announced today that it has commenced tender […]
Costamare Inc. to Hold Virtual Annual Meeting of Stockholders for 2020
MONACO, Sept. 16, 2020 (GLOBE NEWSWIRE) — Costamare Inc. (the “Company”) (NYSE: CMRE), an international owner and provider of containerships […]
Primoris Services Corporation to Participate in Several Investor Conferences in September
DALLAS, Sept. 16, 2020 (GLOBE NEWSWIRE) — Primoris Services Corporation (NASDAQ Global Select: PRIM) (“Primoris” or “Company”) will be participating […]
Collaborative Research by OpGen Group Company Ares Genetics and Johns Hopkins Researchers Demonstrates Potential of Next-Generation Sequencing for Investigation of Genetic Antimicrobial Resistance Mechanisms and Molecular Susceptibility Testing
Published Study on Modifiable Risk Factors for the Emergence of Ceftolozane-Tazobactam ResistancePresented Study on Long-Read Sequencing to Predict Phenotypic Antimicrobial […]
vTv Therapeutics to Present Additional Positive Clinical Study Results from Phase 2 Simplici-T1 Study of TTP399 as Adjunctive Therapy for Patients with Type 1 Diabetes at EASD Virtual Meeting
HIGH POINT, N.C., Sept. 16, 2020 (GLOBE NEWSWIRE) — vTv Therapeutics Inc. (Nasdaq: VTVT) today announced it will deliver two oral […]
PINTEC to Report Half Year 2020 Financial Results on September 21, 2020
BEIJING, Sept. 16, 2020 (GLOBE NEWSWIRE) — Pintec Technology Holdings Limited (Nasdaq: PT) (“PINTEC” or the “Company”), a leading independent […]
